Journal
CELL REPORTS
Volume 26, Issue 7, Pages 1718-+Publisher
CELL PRESS
DOI: 10.1016/j.celrep.2019.01.069
Keywords
-
Categories
Funding
- Oak Ridge Institute for Science and Education
- FDA's Office of Counter-terrorism and Emergency Coordination
- NATIONAL EYE INSTITUTE [ZIAEY000184] Funding Source: NIH RePORTER
Ask authors/readers for more resources
Zaire Ebola virus (ZEBOV) survivors experience visual and CNS sequelae that suggests the ZEBOV glycoprotein can mediate neurotropism. Replication-competent rVSV Delta G-ZEBOV-GP vaccine candidate is generally well tolerated; however, its potential neurotropism requires careful study. Here, we show that a single inoculation of rVSV Delta G-ZEBOV-GP virus in neonatal C57BL/6 mice results in transient viremia, neurological symptoms, high viral titers in eyes and brains, and death. rVSV Delta G-ZEBOV-GP infects the inner layers of the retina, causing severe retinitis. In the cerebellum, rVSV Delta G-ZEBOV-GP infects neurons in the granular and Purkinje layers, resulting in progressive foci of apoptosis and neurodegeneration. The susceptibility to infection is not due to impaired type I IFN responses, although MDA5(-/-), IFN beta(-/-), and IFNAR1(-/-) mice have accelerated mortality. However, boosting interferon levels by co-administering poly(I:C) reduces viral titers in CNS and improves survival. Although these data should not be directly extrapolated to humans, they challenge the hypothesis that VSV-based vaccines are non-neurotropic.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available